Login or Sign Up
Concord Biotech Ltd. Corporate Actions
15:57 Aug 01
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
15:57 Aug 01
Quality
68/100
High Financial Strength
Valuation
29/100
Expensive Valuation
Technical
33/100
Technically Bearish
Strength
10
Weakness
3
Opportunity
0
Threats
1
0.00 %
Dividend Yield
18.21K
Market Cap (Cr)
37.65
RSI
44.08 %
Promoter Holding
30.96 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 21-Jun-2024 | Dividend | 8.75/share@875.00% | 22-Jun-2024 | 875.00 | Final |
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
